Mission

To be an advocate for child health with an emphasis on gastrointestinal, hepatic, and nutritional conditions worldwide.

Button Battery Ingestion Report

International Button Battery Awareness Day (June 12) is rapidly approaching. Do you know of any button battery ingestion cases? Register your report here and receive help from the world's leading experts on the subject. Click on the picture to register a case.

Image

News

28 JULY 2025 World Hepatitis Day
Learn more
12 JUNE 2025 Button Battery Awarness Day
Learn more
7th PIBD 2025 SORRENTO 22-25 October 2025
Learn more
New Leadership of FISPGHAN
New Leadership of FISPGHAN
Learn more
FISPGHAN Statement for World Obesity Day
FISPGHAN Statement for World Obesity Day
Learn more

Meetings

FISPGHAN Outstanding Achievement
FISPGHAN Outstanding Achievement
Learn more
2025
NASPGHAN Annual Meeting
Learn more
The XXV Latin American Congress of LASPGHAN, to be held from September 3 to 6, 2025, in the picturesque city of Mérida, Yucatán, will feature a wide range of academic papers in the areas of nutrition, hepatology, endoscopy, motility, and pediatric gastroenterology in general.  25th Latin American Congress of the Latin American Society of Pediatric Gastroenterology, Hepatology, and Nutrition 2025
2025
XXV Latin American Congress of Pediatric Gastroenterology, Hepatology and Nutrition (LASPGHAN)
Learn more
11th Anual Elite PED-GI Congress 2025
17th Asia Pacific Society for Pediatric Gastroenterology, Hepatology and Nutrition (APSPGHAN)
Learn more



World Hepatitis Day

Image

Endorsement of the Statement from the Self-Selected Group of Pediatric Hepatologists on the Occasion of World Hepatitis Day
28 July 2025

In recognition of World Hepatitis Day, FISPGHAN joins the global call to eliminate hepatitis C infection, particularly in children and adolescents, who are among the most underserved populations affected by this disease.

To whom it may concern:

There are more than 3.2 million children in the world with hepatitis C virus (HCV) infection, the majority of whom acquired from their mothers. It is a tragic irony that although we now have highly effective and safe direct-acting antiviral agents capable of curing HCV in 8-12 weeks in children as young as 3 years of age, the vast majority of these children remain undiagnosed or untreated. Consequently, they face a high lifetime risk of chronic liver disease, cirrhosis, and liver cancer. Multiple studies have shown that eliminating HCV in young children is highly cost-effective, not to mention sparing these unfortunate children from suffering and stigma.

We are therefore recommending the following to

A. Health departments—adopt the screening recommendations of the following:

1) The American Association for the Study of Liver Diseases and the Infectious Disease Society of America (2022) to do one-time screening of all subjects <18 years of age at increased risk for HCV with anti-HCV antibody with reflex testing of HCV RNA.

2) The US Centers for Disease Control and Prevention to test all perinatally exposed infants and children aged 2-17 months, with HCV RNA.

B. Pediatric societies—educate and empower health care providers

1) To perform this screening

2) To treat all HCV-infected children 3 years of age and older

C. Corporations – work with governments to provide the necessary therapeutics and testing at the most reasonable cost basis possible for children and adolescents.

1) To developers of HCV—Real-Time PCR Testing for HCV

2) To pharmaceutical companies have obtained FDA and EMA approval for their direct-acting antiviral agents for children

D. Foundations—work with the four groups below to achieve the elimination of HCV in children worldwide

1) UNICEF

2) GATES FOUNDATION

3) IMPAACT

4) CARTER CENTER

Drafted by the following members of the Group of Pediatric Hepatologists:

Kathleen B. Schwarz, MD, FAASLD, FNASPGHAN, Rady Children’s Hospital/UCSD/ San Diego, CA, USA.

Yen-Hsuan Ni, MD, PhD, National Taiwan University, Taiwan

Anupam Sibal, MD, Group Medical Director, Apollo Hospitals Group, India

Giuseppe Indolfi, MD, PhD, Meyer Children's University Hospital of Florence, Italy

Deirdre Kelly, MD, Children’s NHS Foundation Trust, UK

Patricia D’Alia MD, Hospital General de Niños Pedro de Elizalde, Argentina

Carol Lezama Elecharri, MD, Hospital General de Niños Ricardo Gutierrez, Argentina

Carmen Esther Lopez Gudel, MD, Venezuela

Natascha Silva Sandy, MD, PhD, Hospital Israelita Albert Einstein, Brazil

Learn more about us

Our Activities & Programmes

About Us

About Us

FISPGHAN was founded in the year 2000
News

News

Get the latest news and activities

Publications

Publications

Society Publications | Guidelines
Education

Education

Healthcare Professionals

Meetings

Meetings

Societies meetings calendars
Education

Education

Patients and families

OUR council

FISPGHAN

MEMBERS